Training for better Alzheimer's care in American Indian and Alaska Native clinics

Indian Transforming Alzheimer's Care Training (INTACT)

This study is testing a new training program for doctors in American Indian and Alaska Native clinics to see if it helps them better detect and manage Alzheimer's disease and Mild Cognitive Impairment in their patients.

Quick facts

• Phase: Not applicable
• Study type: Interventional
• Enrollment: 28 (estimated)
• Ages: 18 Years and up
• Sex: All
• Sponsor: Washington State University (Academic / other)
• Locations: 1 site (Seattle, Washington)
• Trial ID: NCT06397339 on ClinicalTrials.gov

What this trial studies

The INTACT program aims to improve the detection and management of Alzheimer's disease and Mild Cognitive Impairment among American Indian and Alaska Native patients by implementing a culturally informed training for primary care providers. This group-randomized trial will involve 28 urban and rural clinics, where clinics will be randomized to either receive the intervention immediately or serve as a wait-list control. Data will be collected from provider questionnaires, electronic health records, and manual chart reviews to assess the program's effectiveness over a one-year period. The focus is on enhancing provider knowledge and confidence in dementia care and improving patient outcomes.

Who should consider this trial

Good fit: Ideal candidates for this study are primary care clinics serving American Indian and Alaska Native patients aged 55 and older with active electronic health records.

Not a fit: Patients who are not part of the American Indian and Alaska Native populations or those under 55 years old may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could lead to earlier detection and better management of Alzheimer's disease in American Indian and Alaska Native populations.

How similar studies have performed: Other studies have shown success with culturally tailored interventions in improving healthcare outcomes for minority populations, suggesting potential for this approach.

Eligibility criteria

CLINIC Eligibility criteria

To be eligible to participate in INTACT a clinic must be:

1. A primary care clinic
2. Have at least 20 AI/AN active patients 55 years or older
3. Have an EHR system
4. Not intending to change EHR systems in the next year
5. Willing to conduct a total of 40 limited patient chart reviews to assess quality of care metrics for AI/AN patients with MCI and ADRD, staff permitting

PCP

Eligibility criteria:

To be eligible to participate in the baseline and follow-up surveys a primary care provider must be:

1. have a title of MD, DO, Nurse Practitioner, or PA, and
2. regularly provides care to AI/ANs aged 65 and older.

PATIENTS

We will only collect patient EHR data from eligible patients who:

1. Recorded as AI/AN in the EHR system
2. Active clinic patient with prevalent ADRD as of the first day of the time period each data extraction will cover
3. Age 55 or older at the start of the surveillance interval
4. At least one primary care clinic visit during the time period each data extraction will cover.

There are no exclusion criteria for the clinic, PCPs and patients.

Where this trial is running

Seattle, Washington

• Washington State University — Seattle, Washington, United States (Recruiting)

Study contacts

• Study coordinator: Patrik Johansson, MD, MPH

Conditions Alzheimer Disease; ADRD, MCI